- Home
- ARWR vs ENVA Comparison
ARWR vs ENVA Comparison
Compare ARWR & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ENVA
- Stock Information
- Founded
- ARWR 2003
- ENVA 2011
- Country
- ARWR United States
- ENVA United States
- Employees
- ARWR N/A
- ENVA N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ENVA Finance: Consumer Services
- Sector
- ARWR Health Care
- ENVA Finance
- Exchange
- ARWR Nasdaq
- ENVA Nasdaq
- Market Cap
- ARWR 2.4B
- ENVA 2.6B
- IPO Year
- ARWR 1993
- ENVA N/A
- Fundamental
- Price
- ARWR $19.56
- ENVA $107.65
- Analyst Decision
- ARWR Buy
- ENVA Buy
- Analyst Count
- ARWR 11
- ENVA 7
- Target Price
- ARWR $43.33
- ENVA $88.00
- AVG Volume (30 Days)
- ARWR 1.5M
- ENVA 237.4K
- Earning Date
- ARWR 02-04-2025
- ENVA 01-28-2025
- Dividend Yield
- ARWR N/A
- ENVA N/A
- EPS Growth
- ARWR N/A
- ENVA 5.61
- EPS
- ARWR N/A
- ENVA 6.23
- Revenue
- ARWR $3,551,000.00
- ENVA $1,170,788,000.00
- Revenue This Year
- ARWR $3,402.96
- ENVA N/A
- Revenue Next Year
- ARWR $123.96
- ENVA $17.19
- P/E Ratio
- ARWR N/A
- ENVA $17.27
- Revenue Growth
- ARWR N/A
- ENVA 14.80
- 52 Week Low
- ARWR $17.05
- ENVA $53.17
- 52 Week High
- ARWR $36.72
- ENVA $108.20
- Technical
- Relative Strength Index (RSI)
- ARWR 47.89
- ENVA 66.35
- Support Level
- ARWR $17.75
- ENVA $93.99
- Resistance Level
- ARWR $19.19
- ENVA $100.54
- Average True Range (ATR)
- ARWR 1.04
- ENVA 2.57
- MACD
- ARWR 0.04
- ENVA 1.15
- Stochastic Oscillator
- ARWR 59.74
- ENVA 96.10
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About ENVA Enova International Inc.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and the United Kingdom. Consumers apply for credit online, receive a decision almost immediately, and can receive funds within one day. Enova acts as either the lender or a third-party facilitator between borrowers and other lenders. The company earns revenue from interest income, finance charges, and other fees, including fees on the transactions between borrowers and third-party lenders. The majority of revenue comes from the United States. The company realizes similar amounts of revenue from each of its three different products: short-term loans, lines of credit, and installment loans.